Showing 281-290 of 4005 results for "".
An Overview of Current Management Limitations
https://reachmd.com/programs/cme/An-Overview-of-Current-Management-Limitations/35968/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.How Does the Skin Repair Itself? A Study on Skin Regeneration
https://reachmd.com/programs/dermconsult/how-does-the-skin-repair-itself-a-study-on-skin-regeneration/12638/What’s the latest research on skin regeneration, and how might it influence the regeneration of other tissues and organs?MacTel Type 2: A Misnomer?
https://reachmd.com/programs/cme/MacTel-Type-2-A-Misnomer/35969/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Quality of Life in MacTel Type 2
https://reachmd.com/programs/cme/Quality-of-Life-in-MacTel-Type-2/35967/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.New Therapies: The Basics
https://reachmd.com/programs/cme/New-Therapies-The-Basics/35970/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.The Road Ahead – Integrating Research Into Practice
https://reachmd.com/programs/cme/The-Road-Ahead-Integrating-Research-Into-Practice/35973/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Analyzing Clinical Trial Data: Part 1
https://reachmd.com/programs/cme/Analyzing-Clinical-Trial-Data-Part-1/35971/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Analyzing Clinical Trial Data: Part 2
https://reachmd.com/programs/cme/Analyzing-Clinical-Trial-Data-Part-2/35972/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Biomarkers for Ulcerative Colitis Management: A Review of the AGA Guidelines
https://reachmd.com/programs/gi-insights/biomarkers-for-ulcerative-colitis-management-a-review-of-the-aga-guidelines/15446/Catch up on what the latest guideline from the AGA says about the role of biomarkers for the management of ulcerative colitis.Diagnosing and Tracking the Progression of MacTel Type 2
https://reachmd.com/programs/cme/Diagnosing-and-Tracking-the-Progression-of-MacTel-Type-2/35964/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.